US Broker Ratings

PureTech Health plc (PRTC) Stock Analysis: Capitalizing on a 166.82% Potential Upside

For investors eyeing the biotechnology sector, PureTech Health plc (PRTC) presents an intriguing opportunity. With a market capitalization of $416.66 million, this Boston-based company is making..

Claritev Corporation (CTEV) Stock Analysis: A Promising Upside of 29.12% Amidst Healthcare Innovations

Claritev Corporation (NASDAQ: CTEV) is carving a niche in the healthcare sector with its innovative solutions in health information services. Headquartered in New York, this company..

Abivax SA (ABVX) Stock Analysis: A Biotech Bet with 12.85% Upside Potential

Abivax SA (ABVX), a trailblazer in the biotechnology sector, is capturing the attention of investors with its promising potential for growth, particularly in the treatment of..

Inventiva S.A. (IVA) Stock Analysis: A Biotech with 279.78% Potential Upside and Strong Buy Ratings

Inventiva S.A. – American Depositary Shares (IVA) is making waves in the biotechnology sector with its promising drug pipeline and a staggering potential upside of 279.78%...

Fortrea Holdings Inc. (FTRE): Navigating the Biotech Landscape with a Strategic Edge

In the rapidly evolving biotechnology industry, Fortrea Holdings Inc. (NASDAQ: FTRE) stands out as a key player, offering a range of critical services that propel biopharmaceutical..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a 58% Potential Upside Amid Industry Challenges

Standard BioTools Inc. (NASDAQ: LAB) presents a compelling yet complex proposition for investors eyeing the healthcare sector, specifically in the medical devices industry. With a market..

SIGA Technologies Inc. (SIGA) Stock Analysis: Unpacking a 271.90% Revenue Growth in the Health Security Market

SIGA Technologies Inc. (SIGA), a prominent player in the healthcare sector, has seen a remarkable trajectory in its financial performance, spotlighted by a staggering 271.90% revenue..

Maze Therapeutics, Inc. (MAZE): Investor Outlook on a Biotech with 27.69% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) is drawing the attention of investors with its promising portfolio and impressive upside potential. This clinical-stage biopharmaceutical company, headquartered in South..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Evaluating a 30.98% Potential Upside in the Diagnostics Sector

For investors with an eye on the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents an intriguing opportunity. As a key player in the diagnostics and..

Akso Health Group (AHG): Unpacking the Remarkable 415.8% Revenue Growth Amid Uncertain Valuations

Investors with an eye on the healthcare sector may find Akso Health Group (NASDAQ: AHG) an intriguing prospect. Despite its relatively modest market capitalization of $928.15..

Cross Country Healthcare (CCRN) Stock Analysis: Unpacking a 42.71% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is navigating the complex landscape of healthcare staffing, a sector that has experienced fluctuating demand dynamics since the pandemic. With..

Humacyte, Inc. (HUMA) Stock Analysis: Analyst Ratings Suggest a 532% Potential Upside

Humacyte, Inc. (NASDAQ: HUMA) is making waves in the biotechnology sector with its promising pipeline of bioengineered human tissues. Despite its current market challenges, the company’s..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Analyst Ratings Signal 105% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a regenerative medicine company specializing in advanced wound care and surgical products, presents a compelling investment opportunity with significant potential upside...

ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Giant with 179% Upside Potential

ATAI Life Sciences N.V. (NASDAQ: ATAI) presents a compelling narrative for investors seeking opportunities in the burgeoning field of mental health treatment biotechnology. Headquartered in Amstelveen,..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 5.6% Upside Potential in the Healthcare Sector

Community Health Systems, Inc. (NYSE: CYH) operates within the healthcare sector, specifically in the medical care facilities industry in the United States. With a market capitalization..

Fulgent Genetics, Inc. (FLGT): Investor Outlook Reveals a 13.55% Potential Upside in the Diagnostics & Research Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a prominent player in the healthcare sector, offering innovative solutions in the diagnostics and research industry. Headquartered in El Monte,..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a Focus on Revenue Growth

Investors with an interest in the healthcare sector, particularly those focused on medical care facilities, may find Sonida Senior Living, Inc. (NYSE: SNDA) to be a..

Upstream Bio, Inc. (UPB) Stock Analysis: A 110% Potential Upside with Strong Buy Ratings

Investors with an eye on the biotechnology sector should take a close look at Upstream Bio, Inc. (UPB), a clinical-stage company focused on developing treatments for..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Eyeing a 31% Upside Potential for Strategic Investors

Emergent BioSolutions Inc. (NYSE: EBS) finds itself at a pivotal juncture, presenting intriguing opportunities for investors keen on the healthcare sector. As a prominent player in..

COMPASS Pathways Plc (CMPS) Stock Analysis: Is a 182% Upside in Reach for This Biotech Pioneer?

COMPASS Pathways Plc (NASDAQ: CMPS) is capturing the attention of investors with its pioneering approach to mental health treatment through innovative psilocybin therapies. As a part..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds